Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 1, 2012 (14 years ago)

Cardiogen-82 (Rubidium Chloride Rb-82)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

GMP deviation; Sr-82 levels exceeded alert limit specification

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

CARDIOGEN-82 (Rubidium Rb 82 Generator), 140 millicurie, Rx Only, For Elution of sterile nonpyrogenic Rubidium Chloride Rb 82, Manufactured for: Bracco Diagnostics Inc. Princeton, NJ 08543 by Medi-Physics, Inc. South Plainfield, NJ 07080, NDC 0270-0091-01

Affected NDC 0270-0091-01

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
CardioGen-82
Rubidium Chloride RB-82
NDC 00270-0091
150 mCi/1 Injection, Solution
Intravenous
Bracco Diagnostics Inc Rx
Recalling firm
Bracco Diagnostics Inc
NDC code
0270-0091-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1684-2012 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Bracco Diagnostics Inc

All 2012 recalls
Class II · Moderate risk

E-Z-Paste Barium Sulfate Esophageal Cream

Failed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of one lot.

Terminated Stability / shelf life Bracco Diagnostics Inc. NDC 32909-770-01 D-0609-2018
Class III · Low risk

Tagitol V Barium Sulfate Suspension

Failed Stability Specifications: Tagitol V Barium Sulfate Lot #65846 sampled at 10 months exhibited results above the upper specification for viscosity.

Terminated Stability / shelf life Bracco Diagnostics Inc NDC 32909-814-53 D-914-2013
Class II · Moderate risk

Gastrografin

Presence of foreign substance: One lot of the product may contain black foreign particles

Terminated Particulate / foreign matter Bracco Diagnostics Inc NDC 0270-0445-40 D-885-2013

Other cgmp deviation recalls from 2012

All cgmp deviation recalls
Class II · Moderate risk

ABILIFY (aripiprazole)

CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.

Terminated cGMP deviation Bristol Myers Squibb Manufacturing Company NDC 59148-011-35 D-181-2013
Class III · Low risk

Lemon Hand Sanitizing Wipes

CGMP Deviations: The products were manufactured with raw material which contain unknown particles believed to be water and dirt.

Terminated cGMP deviation ITW Dymon D-056-2013